Application of digital pathology‐based advanced analytics of tumour microenvironment organisation to predict prognosis and therapeutic response
暂无分享,去创建一个
[1] P. Siegel,et al. Single-cell spatial landscapes of the lung tumour immune microenvironment , 2023, Nature.
[2] P. Siegel,et al. Single-cell spatial immune landscapes of primary and metastatic brain tumours , 2023, Nature.
[3] S. Ather,et al. DECIDE-AI: a new reporting guideline and its relevance to artificial intelligence studies in radiology. , 2023, Clinical radiology.
[4] Jakob Nikolas Kather,et al. Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer , 2023, Nature Medicine.
[5] Eric W. Tramel,et al. Federated learning for predicting histological response to neoadjuvant chemotherapy in triple-negative breast cancer , 2023, Nature Medicine.
[6] Thomas J. Fuchs,et al. Clinical Validation of Artificial Intelligence-Augmented Pathology Diagnosis Demonstrates Significant Gains in Diagnostic Accuracy in Prostate Cancer Detection. , 2022, Archives of pathology & laboratory medicine.
[7] Ming Y. Lu,et al. A deep-learning model for transforming the style of tissue images from cryosectioned to formalin-fixed and paraffin-embedded , 2022, Nature Biomedical Engineering.
[8] Alexandro E. Trevino,et al. Graph deep learning for the characterization of tumour microenvironments from spatial protein profiles in tissue specimens , 2022, Nature Biomedical Engineering.
[9] Michelle M. Li,et al. Graph representation learning in biomedicine and healthcare , 2022, Nature Biomedical Engineering.
[10] Zachary R. Lewis,et al. High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging. , 2022, Nature biotechnology.
[11] Ming Y. Lu,et al. Artificial intelligence for multimodal data integration in oncology. , 2022, Cancer cell.
[12] Jakob Nikolas Kather,et al. Artificial intelligence in histopathology: enhancing cancer research and clinical oncology , 2022, Nature Cancer.
[13] D. Miklos,et al. Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma , 2022, Nature Medicine.
[14] Ming Y. Lu,et al. Pan-cancer integrative histology-genomic analysis via multimodal deep learning. , 2022, Cancer cell.
[15] R. Socher,et al. Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials , 2022, npj Digital Medicine.
[16] Heather A. Harrington,et al. Multiscale topology characterizes dynamic tumor vascular networks , 2022, Science advances.
[17] Spiros C. Denaxas,et al. Reporting guideline for the early stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI , 2022, BMJ.
[18] Spiros C. Denaxas,et al. Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI , 2022, Nature Medicine.
[19] I. Ellis,et al. Breast tumor microenvironment structures are associated with genomic features and clinical outcome , 2022, Nature Genetics.
[20] Nils Eling,et al. Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapy , 2022, Science Immunology.
[21] H. Najafabadi,et al. Spatially mapping the immune landscape of melanoma using imaging mass cytometry , 2022, Science Immunology.
[22] O. Elemento,et al. Unsupervised discovery of tissue architecture in multiplexed imaging , 2022, bioRxiv.
[23] T. Kiehl,et al. The explainability paradox: Challenges for xAI in digital pathology , 2022, Future Gener. Comput. Syst..
[24] S. Ishikawa,et al. Universal encoding of pan-cancer histology by deep texture representations. , 2022, Cell reports.
[25] S. Devries,et al. An AI-derived digital pathology-based biomarker to predict the benefit of androgen deprivation therapy in localized prostate cancer with validation in NRG/RTOG 9408. , 2022, Journal of Clinical Oncology.
[26] Garry P. Nolan,et al. Identification of cell types in multiplexed in situ images by combining protein expression and spatial information using CELESTA , 2022, Nature Methods.
[27] Po-Hsuan Cameron Chen,et al. Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge , 2022, Nature Medicine.
[28] S. Tavaré,et al. Three-dimensional imaging mass cytometry for highly multiplexed molecular and cellular mapping of tissues and the tumor microenvironment , 2021, Nature Cancer.
[29] Shujing Jane Lim,et al. Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension. , 2021, The Lancet. Oncology.
[30] W. Hahn,et al. Biologically informed deep neural network for prostate cancer discovery , 2021, Nature.
[31] J. Taube,et al. Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE) Study , 2021, Journal for ImmunoTherapy of Cancer.
[32] B. Delahunt,et al. ISUP Consensus Definition of Cribriform Pattern Prostate Cancer , 2021, The American journal of surgical pathology.
[33] Cody N. Heiser,et al. Multiplexed 3D atlas of state transitions and immune interactions in colorectal cancer , 2021, bioRxiv.
[34] Andrew H. Beck,et al. Human-interpretable image features derived from densely mapped cancer pathology slides predict diverse molecular phenotypes , 2021, Nature Communications.
[35] D. Moher,et al. Reporting guidelines for clinical trials of artificial intelligence interventions: the SPIRIT-AI and CONSORT-AI guidelines , 2021, Trials.
[36] Salil S. Bhate,et al. Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma , 2020, Nature Communications.
[37] A. Kishan,et al. A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer. , 2020, European urology.
[38] Jakob Nikolas Kather,et al. Deep learning in cancer pathology: a new generation of clinical biomarkers , 2020, British Journal of Cancer.
[39] Cecilia S. Lee,et al. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. , 2020, The Lancet. Digital health.
[40] Zhongping Zhang,et al. Automatic Prediction of MGMT Status in Glioblastoma via Deep Learning-Based MR Image Analysis , 2020, BioMed research international.
[41] Gary S Collins,et al. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension , 2020, BMJ.
[42] Cecilia S Lee,et al. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension , 2020, Nature Medicine.
[43] Sangwoo Lee,et al. Liver imaging features by convolutional neural network to predict the metachronous liver metastasis in stage I-III colorectal cancer patients based on preoperative abdominal CT scan , 2020, BMC Bioinformatics.
[44] Gary S Collins,et al. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension , 2020, Nature Medicine.
[45] J. Galon,et al. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy , 2020, Nature Reviews Cancer.
[46] J. Galon,et al. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy , 2020, Nature Reviews Cancer.
[47] Yuming Liu,et al. Non-disruptive collagen characterization in clinical histopathology using cross-modality image synthesis , 2020, Communications Biology.
[48] Salil S. Bhate,et al. Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front , 2020, Cell.
[49] K. Sirinukunwattana,et al. Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning , 2020, Gut.
[50] M. Salto‐Tellez,et al. A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment , 2020, Molecular oncology.
[51] Ming Y. Lu,et al. AI-based pathology predicts origins for cancers of unknown primary , 2020, Nature.
[52] Stefano Trebeschi,et al. Machine learning-based analysis of CT radiomics model for prediction of colorectal metachronous liver metastases , 2020, Abdominal Radiology.
[53] James Y. Zou,et al. Integrating spatial gene expression and breast tumour morphology via deep learning , 2020, Nature Biomedical Engineering.
[54] A. Darzi,et al. Developing specific reporting guidelines for diagnostic accuracy studies assessing AI interventions: The STARD-AI Steering Group , 2020, Nature Medicine.
[55] Angela E. Leek,et al. Geospatial immune variability illuminates differential evolution of lung adenocarcinoma , 2020, Nature Medicine.
[56] Ming Y. Lu,et al. Data-efficient and weakly supervised computational pathology on whole-slide images , 2020, Nature Biomedical Engineering.
[57] Clinton J. V. Campbell,et al. Pan-cancer diagnostic consensus through searching archival histopathology images using artificial intelligence. , 2020, NPJ digital medicine.
[58] R. Jain,et al. A framework for advancing our understanding of cancer-associated fibroblasts , 2020, Nature Reviews Cancer.
[59] H. Moch,et al. The single-cell pathology landscape of breast cancer , 2020, Nature.
[60] Kimmo Kartasalo,et al. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. , 2020, The Lancet. Oncology.
[61] E. Sahai,et al. Topological Tumor Graphs: a graph-based spatial model to infer stromal recruitment for immunosuppression in melanoma histology. , 2019, Cancer research.
[62] Danielle Park,et al. A FIJI macro for quantifying pattern in extracellular matrix , 2019, Life Science Alliance.
[63] Morteza Babaie,et al. Pan-cancer diagnostic consensus through searching archival histopathology images using artificial intelligence , 2019, npj Digital Medicine.
[64] Jakob Nikolas Kather,et al. Pan-cancer image-based detection of clinically actionable genetic alterations , 2019, Nature Cancer.
[65] Ming Y. Lu,et al. Weakly Supervised Prostate Tma Classification Via Graph Convolutional Networks , 2019, 2020 IEEE 17th International Symposium on Biomedical Imaging (ISBI).
[66] Alexander W. Jung,et al. Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis , 2019, Nature Cancer.
[67] G. Wainrib,et al. Deep learning-based classification of mesothelioma improves prediction of patient outcome , 2019, Nature Medicine.
[68] Garry Nolan,et al. MIBI-TOF: A multiplexed imaging platform relates cellular phenotypes and tissue structure , 2019, Science Advances.
[69] Honglak Lee,et al. Near real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networks , 2019, Nature Medicine.
[70] Timo Kohlberger,et al. An augmented reality microscope with real-time artificial intelligence integration for cancer diagnosis , 2019, Nature Medicine.
[71] A. Madabhushi,et al. Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology , 2019, Nature reviews. Clinical oncology.
[72] Thomas J. Fuchs,et al. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images , 2019, Nature Medicine.
[73] Gary S. Collins,et al. Reporting of artificial intelligence prediction models , 2019, The Lancet.
[74] Jakob Nikolas Kather,et al. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer , 2019, Nature Medicine.
[75] Constantino Carlos Reyes-Aldasoro,et al. Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study , 2019, PLoS medicine.
[76] Jin Tae Kwak,et al. Hover-Net: Simultaneous segmentation and classification of nuclei in multi-tissue histology images , 2018, Medical Image Anal..
[77] Cynthia Rudin,et al. Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead , 2018, Nature Machine Intelligence.
[78] Richard J. Chen,et al. Deep Adversarial Training for Multi-Organ Nuclei Segmentation in Histopathology Images , 2018, IEEE Transactions on Medical Imaging.
[79] N. Razavian,et al. Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning , 2018, Nature Medicine.
[80] Jakob Nikolas Kather,et al. Topography of cancer-associated immune cells in human solid tumors , 2018, eLife.
[81] Sean C. Bendall,et al. A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging , 2018, Cell.
[82] W. Sauerbrei,et al. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration , 2018, Journal of the National Cancer Institute.
[83] Virginia G Kaklamani,et al. Adjuvant Chemotherapy Guided by a 21‐Gene Expression Assay in Breast Cancer , 2018, The New England journal of medicine.
[84] F. Marincola,et al. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study , 2018, The Lancet.
[85] Rajarsi R. Gupta,et al. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images. , 2018, Cell reports.
[86] R. Figlin,et al. A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcome , 2017, Scientific Reports.
[87] D. Brat,et al. Predicting cancer outcomes from histology and genomics using convolutional networks , 2017, Proceedings of the National Academy of Sciences.
[88] A Harbias,et al. Implications of Observer Variation in Gleason Scoring of Prostate Cancer on Clinical Management: A Collaborative Audit. , 2017, The Gulf journal of oncology.
[89] Laurence Zitvogel,et al. The immune contexture in cancer prognosis and treatment , 2017, Nature Reviews Clinical Oncology.
[90] E. Sahai,et al. Tumor Microenvironment and Differential Responses to Therapy. , 2017, Cold Spring Harbor perspectives in medicine.
[91] Peter Bankhead,et al. QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.
[92] B. Krishnamachary,et al. Structure and Function of a Prostate Cancer Dissemination–Permissive Extracellular Matrix , 2016, Clinical Cancer Research.
[93] Patricia D. Castro,et al. Positive association of collagen type I with non-muscle invasive bladder cancer progression , 2016, Oncotarget.
[94] Andrew J. Schaumberg,et al. D R A F T H&E-stained Whole Slide Image Deep Learning Predicts SPOP Mutation State in Prostate Cancer , 2017 .
[95] Holger Moch,et al. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours. , 2016, European urology.
[96] N. Rajpoot,et al. Locality Sensitive Deep Learning for Detection and Classification of Nuclei in Routine Colon Cancer Histology Images , 2016, IEEE Trans. Medical Imaging.
[97] Chris Bakal,et al. Microenvironmental Heterogeneity Parallels Breast Cancer Progression: A Histology–Genomic Integration Analysis , 2016, PLoS medicine.
[98] Angela E. Leek,et al. Increased peri-ductal collagen micro-organization may contribute to raised mammographic density , 2016, Breast Cancer Research.
[99] B. Delahunt,et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System , 2015, The American journal of surgical pathology.
[100] Robert P. Jenkins,et al. Dendritic Cells Control Fibroblastic Reticular Network Tension and Lymph Node Expansion , 2014, Nature.
[101] J. Buhmann,et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry , 2014, Nature Methods.
[102] Konradin Metze,et al. Fractal dimension of chromatin: potential molecular diagnostic applications for cancer prognosis , 2013, Expert review of molecular diagnostics.
[103] Jack Cuzick,et al. Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[104] P. Royston,et al. External validation of a Cox prognostic model: principles and methods , 2013, BMC Medical Research Methodology.
[105] David Moher,et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials , 2013, BMJ.
[106] F. Markowetz,et al. Quantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling , 2012, Science Translational Medicine.
[107] Douglas G Altman,et al. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration , 2012, BMC Medicine.
[108] C. Sautès-Fridman,et al. The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.
[109] Pierre Validire,et al. Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors. , 2012, The Journal of clinical investigation.
[110] Andrew H. Beck,et al. Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival , 2011, Science Translational Medicine.
[111] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[112] K. Eliceiri,et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. , 2011, The American journal of pathology.
[113] Konradin Metze,et al. Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma , 2010, BMC Cancer.
[114] D. Moher,et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.
[115] D. Moher,et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2011, BMJ : British Medical Journal.
[116] Ian O Ellis,et al. Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[117] B. Ho,et al. Preoperative and intraoperative diagnosis of low‐grade adenosquamous carcinoma of the breast: potential diagnostic pitfalls , 2006, Histopathology.
[118] Douglas G Altman,et al. REporting recommendations for tumour MARKer prognostic studies (REMARK). , 2005, European journal of cancer.
[119] E. Sabo,et al. Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[120] J. Simpson,et al. Metaplastic breast tumors with a dominant fibromatosis‐like phenotype have a high risk of local recurrence , 1999, Cancer.
[121] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[122] I. Ellis,et al. Histologic grading of breast cancer. Let's do it. , 1995, American journal of clinical pathology.
[123] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[124] Yuming Liu,et al. Computational segmentation of collagen fibers from second-harmonic generation images of breast cancer , 2014, Journal of biomedical optics.
[125] D. Sargent,et al. Clinical Trial Designs for Prospective Validation of Biomarkers , 2005, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.
[126] C. Redmond,et al. Histologic grading of breast cancer. , 1980, Pathology annual.